Year |
Citation |
Score |
2008 |
Castro E, DÃaz A, Rodriguez-Gaztelumendi A, Del Olmo E, Pazos A. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality. Neuropharmacology. 55: 1391-6. PMID 18809415 DOI: 10.1016/j.neuropharm.2008.08.038 |
0.628 |
|
2008 |
Sáiz J, Pazos A, Del Olmo E, Sáiz V, Sánchez A. Yohimbine-induced alterations in alpha(2)-adrenoceptors in kidney regions of the spontaneously hypertensive rats: an autoradiographic analysis. Pharmacological Reports : Pr. 60: 391-8. PMID 18622064 |
0.454 |
|
2006 |
Zazpe A, Artaiz I, Innerárity A, Del Olmo E, Castro E, Labeaga L, Pazos A, Orjales A. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties. Neuropharmacology. 51: 129-40. PMID 16643965 DOI: 10.1016/j.neuropharm.2006.03.008 |
0.516 |
|
2006 |
Ruiz de Azúa I, del Olmo E, Pazos A, Sallés J. Transmembrane signaling through phospholipase C-beta in the developing human prefrontal cortex. Journal of Neuroscience Research. 84: 13-26. PMID 16615043 DOI: 10.1002/jnr.20858 |
0.546 |
|
2005 |
Artaiz I, Zazpe A, Innerárity A, Del Olmo E, DÃaz A, Ruiz-Ortega JA, Castro E, Pena R, Labeaga L, Pazos A, Orjales A. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties. Psychopharmacology. 182: 400-13. PMID 16032410 DOI: 10.1007/s00213-005-0087-3 |
0.685 |
|
2003 |
Mato S, Del Olmo E, Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. The European Journal of Neuroscience. 17: 1747-54. PMID 12752773 DOI: 10.1046/J.1460-9568.2003.02599.X |
0.741 |
|
2003 |
Castro M, Diaz A, del Olmo E, Pazos A. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology. 44: 93-101. PMID 12559126 DOI: 10.1016/S0028-3908(02)00340-4 |
0.669 |
|
2001 |
del Olmo E, Pazos A. Aminergic receptors during the development of the human brain: the contribution of in vitro imaging techniques. Journal of Chemical Neuroanatomy. 22: 101-14. PMID 11470558 DOI: 10.1016/S0891-0618(01)00097-7 |
0.651 |
|
1998 |
Pazos A, Castro ME, del Olmo E, Romón T, del Arco C. Autoradiographic characterization, anatomical distribution, and developmental pattern of a new 5-HT site in human brain. Annals of the New York Academy of Sciences. 861: 262. PMID 9928279 DOI: 10.1111/j.1749-6632.1998.tb10213.x |
0.532 |
|
1998 |
del Olmo E, López-Giménez JF, Vilaró MT, Mengod G, Palacios JM, Pazos A. Early localization of mRNA coding for 5-HT1A receptors in human brain during development. Brain Research. Molecular Brain Research. 60: 123-6. PMID 9748536 DOI: 10.1016/S0169-328X(98)00149-1 |
0.67 |
|
1997 |
Castro ME, Romón T, Castillo MJ, del Olmo E, Pazos A, del Arco C. Identification and characterization of a new serotonergic recognition site with high affinity for 5-carboxamidotryptamine in mammalian brain. Journal of Neurochemistry. 69: 2123-31. PMID 9349558 DOI: 10.1046/J.1471-4159.1997.69052123.X |
0.599 |
|
1997 |
Castro ME, Pascual J, Romón T, del Arco C, del Olmo E, Pazos A. Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord. Neuropharmacology. 36: 535-42. PMID 9225278 DOI: 10.1016/S0028-3908(97)00061-0 |
0.654 |
|
1996 |
Pascual J, del Arco C, Romón T, del Olmo E, Castro E, Pazos A. Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia : An International Journal of Headache. 16: 317-22. PMID 8869766 DOI: 10.1046/J.1468-2982.1996.1605317.X |
0.655 |
|
1996 |
Pascual J, Del Arco C, Romón T, Del Olmo E, Pazos A. [3H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT1D and 5-HT1F receptors. European Journal of Pharmacology. 295: 271-4. PMID 8720594 DOI: 10.1016/0014-2999(95)00748-2 |
0.649 |
|
1996 |
del Olmo E, del Arco C, DÃaz A, Pascual J, Mengod G, Palacios JM, Pazos A. Ontogenetic development of 5-HT1D receptors in human brain: an autoradiographic study. The European Journal of Neuroscience. 8: 53-60. PMID 8713449 DOI: 10.1111/J.1460-9568.1996.Tb01166.X |
0.741 |
|
1994 |
del Olmo E, DÃaz A, Guirao-Piñeyro M, del Arco C, Pascual J, Pazos A. Transient localization of 5-HT1A receptors in human cerebellum during development. Neuroscience Letters. 166: 149-52. PMID 8177491 DOI: 10.1016/0304-3940(94)90472-3 |
0.67 |
|
1994 |
Pascual J, Figols J, Grijalba B, González AM, del Olmo E, Berciano J, Pazos A. Changes in aminergic receptors in a PSP postmortem brain: correlation with pathological findings. Journal of Neural Transmission. Supplementum. 42: 247-60. PMID 7964690 DOI: 10.1007/978-3-7091-6641-3_19 |
0.734 |
|
1992 |
Pascual J, Berciano J, Grijalba B, del Olmo E, González AM, Figols J, Pazos A. Dopamine D1 and D2 receptors in progressive supranuclear palsy: an autoradiographic study. Annals of Neurology. 32: 703-7. PMID 1449252 DOI: 10.1002/Ana.410320516 |
0.716 |
|
1992 |
Lafarga M, Berciano MT, Del Olmo E, Andres MA, Pazos A. Osmotic stimulation induces changes in the expression of beta-adrenergic receptors and nuclear volume of astrocytes in supraoptic nucleus of the rat. Brain Research. 588: 311-6. PMID 1327410 DOI: 10.1016/0006-8993(92)91592-3 |
0.467 |
|
1991 |
Pascual J, Pazos A, del Olmo E, Figols J, Leno C, Berciano J. Presynaptic parkinsonism in olivopontocerebellar atrophy: clinical, pathological, and neurochemical evidence. Annals of Neurology. 30: 425-8. PMID 1952831 DOI: 10.1002/ana.410300318 |
0.518 |
|
1991 |
Pascual J, del Arco C, González AM, DÃaz A, del Olmo E, Pazos A. Regionally specific age-dependent decline in alpha 2-adrenoceptors: an autoradiographic study in human brain. Neuroscience Letters. 133: 279-83. PMID 1687760 DOI: 10.1016/0304-3940(91)90588-K |
0.675 |
|
Show low-probability matches. |